Clinical, pathogenetic, and diagnostic features of heart failure in patients with coronary heart disease and thyrotoxicosis

by A. I. Chesnikova, E. V. Pashchenko, V. P. Terentyev, V. I. Kudinov
Published 2019-11-01

CLINICAL SIGNIFICANCE OF DETERMINING THE LEVEL OF THE BRAIN NATRIURETIC PEPTIDE FOR THE DIAGNOSIS OF HEART FAILURE OF COMORBID PATIENTS WITH CORONARY HEART DISEASE AND THYROTOXICOS...

by E. V. Pashchenko, A. I. Chesnikova, V. I. Kudinov, V. P. Terent’ev
Published 2017-09-01

STRUCTURAL AND FUNCTIONAL FEATURES OF LEFT VENTRICLE IN PATIENTS WITH HEART FAILURE, CORONARY HEART DISEASE AND THYROTOXICOSIS

by E. V. PASHCHENKO, A. I. CHESNIKOVA, V. P. TERENTYEV, V. I. KUDINOV, E. A. DEVETYAROVA
Published 2018-10-01

The role of thyrostatic agents in the treatment of chronic heart failure patients with comorbid coronary artery disease and thyrotoxicosis

by E. V. Pashchenko, A. I. Chesnikova, V. P. Terentyev, V. I. Kudinov, M. S. Lankina, L. S. Matveychuk
Published 2021-06-01

VOZMOZhNOSTI KORREKTsII GIPOGLIKEMIChESKOGO SINDROMA S TsEL'Yu PREDUPREZhDENIYa PROGRESSIROVANIYa MAKROSOSUDISTYKh OSLOZhNENIY SAKhARNOGO DIABETA 2 TIPA

by V. I. Kudinov, A. I. Chesnikova, M. S. Nichitenko, I. V. Kulikovskikh, N. V. Zolotareva, N. A. Korsun
Published 2011-12-01